Together, these results indicate that there is a cancer intrinsic TNFRSF14 elevation in GBM accompanying with IFN-γ signaling activation, which may be a potential compensatory mechanism to IFN-γ exposure in GBM and indicate poor prognosis of GBM patients. Here, TNFRSF14 is linked to glioblastoma.